RLS Radiopharmacies purchases Gallium-68 generators for all its locations

IRLS Radiopharmacies is expanding its drug manufacturing capabilities through an agreement with global radioisotope developer Eckert & Ziegler. As part of the supply contract, all 31 of RLS’s radiopharmacies will be equipped with generators capable of producing Gallium-68 pharmaceuticals, which are used for PET imaging cancers.
Read More

Related Posts